Promising HIV vaccine passes phase one human trials with 90% success rate

Re:Promising HIV vaccine passes phase one human trials with ... by Alex3917 on Thursday September 29, 2011 @02:12PM (#3053578)

There are lots of different variables that influence adherence, including but not limited to:

- expected or actual efficacy

- regimen complexity

- knowledge, commitment, and ability

- doctor-patient relationship

My understanding is that with HIV a lot of money has been spent on actually implementing the adherence research in order to reduce the spread of the disease, whereas for most other diseases no one really cares. I think getting diagnosed with HIV also encourages some people to grow up a little bit in a way that getting diagnosed with high blood pressure or whatever doesn't, though maybe less so now that infection vectors are changing.

[ Parent | on HN ]

Re:Promising HIV vaccine passes phase one human trials with ... by cdavoren on Thursday September 29, 2011 @08:54PM (#3055022)

It might also be worth noting that adherence with HIV medication is also motivated by simple fear: if you don't take it, you will die. Painfully, from secondary infection.

Diabetes (type 2) and cardiac disease are scenarios where people can still kid themselves to a certain extent.

[ Parent | on HN ]